Phase 1 Dose-escalation Study of FluBHPVE6E7 in HPV16-infected Women
Clinical trial NCT05829629 · RECRUITING
Trial details
- NCT number
- NCT05829629
- Sponsor
- BlueSky Immunotherapies GmbH
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-12
- Primary completion
- 2025-09-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.